VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’…


Previous articleClearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial
Next articleReunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference